Publication - 2025Impact of Treatment Duration on Response Durability: A Post Hoc Analysis of the TRuE-V Long-Term Extension Study of Ruxolitinib Cream in Vitiligo

Publication

Submitted to Dermatology and Therapy on January 2, 2025. Pending review.

Pearl Grimes, Iltefat H. Hamzavi, Kristen Bibeau, John E. Harris, Nanja van Geel, Davinder Parsad, Jackie Gardner, Yan Valle, MSc, Gaone Tlhong Matewa, Jessy Gao, Haobo Ren, Khaled Ezzedine



FAQOther Questions

  • PTSD in Vitiligo?

    Living with vitiligo often involves more than managing visible skin changes. Many individuals face discrimination, social stigma, and feelings of isolation, leading to emotional...

  • Who is prone to vitiligo?

    Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...

  • Is vitiligo contagious?

    Vitiligo is not contagious. This means it cannot be spread from person to person through physical contact, sharing personal items, or any other means of transmission. Vitiligo ...